DRTS · NASDAQ · Biotechnology

Alpha Tau Medical

Develops Alpha DaRT, a localized alpha-radiation therapy for solid tumors.

$14.85
After-hours close+0.18 (+1.23%)
At close$14.67(−0.95%)
DateEstimateReportedSurprise
Nov 2026−$0.14
Aug 2026−$0.14−$0.50−254.9%
May 2026−$0.13−$0.26−100.0%
Mar 2026−$0.13−$0.14−7.7%
Nov 2025−$0.12−$0.14−16.7%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024−$0.13
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Dec 2020
Sep 2020
Jun 2020
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Mar 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 19, 2026−$0.14$368.3K
Aug 10, 2026−$0.14−$0.50−254.9%$144.5K$100.0K−30.8%
May 18, 2026−$0.13−$0.26−100.0%$49.8K
Mar 9, 2026−$0.13−$0.14−7.7%$63.0K
Nov 20, 2025−$0.12−$0.14−16.7%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Aug 11, 2025
May 19, 2025
Mar 12, 2025
Nov 21, 2024−$0.13
Aug 14, 2024
May 20, 2024
Mar 7, 2024
Nov 16, 2023
Aug 28, 2023
May 23, 2023
Mar 9, 2023
Nov 22, 2022
Aug 25, 2022
May 26, 2022
Mar 28, 2022
Nov 15, 2021
Aug 17, 2021
May 29, 2021
Dec 31, 2020
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019